Consequently, we confirmed an increased diffuse cardiac fibrosis in mice carrying hematopoietic DNMT3A CHIP-driver mutations subjected to myocardial infarction, as well as in patients with established heart failure. The gene discussed is DNMT3A; the disease is myocardial infarction.